Health Insurance (Accredited Pathology Laboratories — Approval) Amendment Principles 2007 (No. 1) (Cth)
Health Insurance (Accredited Pathology Laboratories — Approval) Amendment Principles 2007 (No. 1)
Health Insurance Act 1973
I, ANTONY CHARLES KINGDON, Acting First Assistant Secretary, Medical Benefits Division, Department of Health and Ageing, determine these Principles under subsection 23DNA (1) of the Health Insurance Act 1973.
Dated 22 January 2007
ANTONY KINGDON
Acting First Assistant Secretary, Medical Benefits Division, Department of Health and Ageing
Name of Principles
These Principles are the Health Insurance (Accredited Pathology Laboratories — Approval) Amendment Principles 2007 (No. 1).
Commencement
These Principles commence on 1 July 2007.
Amendment of Health Insurance (Accredited Pathology Laboratories — Approval) Principles 2002
Schedule 1 amends the Health Insurance (Accredited Pathology Laboratories — Approval) Principles 2002.
Schedule 1 Amendments
(section 3)
[1] Subsection 5 (1), definition of accreditation materials
substitute
accreditation materials means each document mentioned in Schedule 1, published in the year mentioned for the document.
[2] Subparagraph 11 (1) (a) (ii)
omit
for
[3] Paragraph 11 (4) (b)
omit
for
[4] Paragraph 12 (3) (a)
before
a representative
insert
that
[5] Paragraphs 12 (3) (b) and (c)
before
the independent body
insert
that
[6] Paragraph 12 (3) (c)
omit
confidence
insert
confidence,
[7] Subparagraph 12 (3) (c) (ii)
substitute
(ii) the premises are, or will be, appropriately staffed with persons to carry out, and persons to direct, control and supervise, the pathology services to be performed at the premises; and
[8] Paragraph 15 (1) (a)
omit
covered by the approval,
insert
covered by the approval
[9] Schedule 1
substitute
Schedule 1 Accreditation materials
(section 5)
Part 1 NPAAC materials
| Item | Material | Publication year |
| 1 | Guidelines for Data Communication | 1998 |
| 2 | Information on the Transport of Pathology Specimens | 1998 |
| 3 | Guidelines for Cytogenetics Laboratories | 2001 |
| 4 | Retention of Laboratory Records and Diagnostic Material | 2002 |
| 5 | Guidelines for Laboratory Procedures Related to the Processing, Storage and Infusion of Cells for Transplantation or Cell Therapy | 2004 |
| 6 | Guidelines for the Facilities and Operation of Hospital and Forensic Mortuaries | 2004 |
| 7 | Standards for Pathology Laboratory Participation in External Proficiency Testing Programs | 2004 |
| 8 | Guidelines for Approved Pathology Collection Centres | 2006 |
| 9 | Guidelines for the Performance of the Pathology Surgical Cut‑up | 2006 |
| 10 | Guidelines for the use of Liquid Based Collection Systems and Semi‑Automated Screening Devices in the Practice of Gynaecological (Cervical) Cytology | 2006 |
| 11 | Laboratory Accreditation Standards and Guidelines for Nucleic Acid Detection and Analysis | 2006 |
| 12 | Performance Measures for Australian Laboratories Reporting Cervical Cytology | 2006 |
| 13 | Requirements for Gynaecological (Cervical) Cytology | 2006 |
| 14 | Requirements for Supervision of Pathology Laboratories | 2006 |
| 15 | Standards and Guidelines for Laboratory Testing of Antibodies to the Human Immunodeficiency Virus (HIV) and the Hepatitis C Virus (HCV) | 2006 |
| 16 | Guidelines for Quality Management in Medical Laboratories | 2007 |
| 17 | Requirements for Pathology Laboratories | 2007 |
| 18 | Requirements for the Development and Use of In‑house In Vitro Diagnostic Devices (IVDs) | 2007 |
| 19 | Requirements for the Estimation of Measurement Uncertainty | 2007 |
Note The documents mentioned in Part 1 are available on the Internet — see 2 Other materials
1. National Association of Testing Authorities NATA AS 4633 (ISO 15189) Application Document — Supplementary Requirements for Accreditation in the Field of Medical Testing, published in 2005.
Note The document mentioned in item 1 is available from the National Association of Testing Authorities — see
0
0
0